MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
PTGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Protagonist Therapeutics (PTGX) Ownership - Who owns Protagonist Therapeutics?

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
132
Web
https://www.protagonist-inc.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.81B
P/E Ratio
133.92
Total Cash
547.79M
Projected Growth
N/A
Total Debt
9.78M
Revenue
74.06M
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
8.52
Total Debt/Equity
N/A
Revenue/Share
1.13 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
PTGX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for PTGX
A.I. Advisor
published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
132
Web
https://www.protagonist-inc.com